Galena Biopharma Announces Reduction Of Cardiac Toxicity Study For Neuvax Trial
August 24, 2015 at 19:39 PM EDT
Shares of Galena Biopharma (GALE) closed the day up 11%, after announcing reduction of cardiac toxicity study for Neuvax trial.